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The purpose of this study was to evaluate the etfect of chronic obstructive pulmonary 
disease on patients undergoing coronary artery bypass grafting. Between June 1991 
and June 1993, 651 patients underwent coronary artery bypass grafting: 37 patients 
(group I) had significant chronic obstructive pulmonary disease. These patients 
were compared with 37 matched control subjects (group II). Comparison of the 
groups was made with regard to postoperative morbidity and mortality. Quality of 
life of survivors was compared at the last follow-up. More patients in group I had 
preoperative arrhythmias (8 versus 1,p = 0.014). Group I patients had lower values 
of forced expiratory volume in 1 second (1.366 -+ 0.032 L versus 2.335 -+ 0.49 L, p < 
0.0001), lower oxygen tension (63.5 l+ 8.2 versus 79.1 -+ 13.4 mm Hg, p = 0.001), and 
higher carbon dioxide tension (44.8 - 6.5 mm Hg versus 39.7 - 3.6 mm Hg, p = 
0.001). After operation patients in group I had a longer hospital stay (8.1 + 3.6 days 
versus 6.6 -+ 1.7 days, p = 0.0236) and longer intensive care unit stay (2.64 - 0.9 
days versus 1.23 _+ 0.49 days, p = 0.0001). More patients in group I required 
prolonged intubation (7 versus 1, p = 0.0278) and reintubation (5 versus 1, p = 
0.088). More patients in group I had significant arrhythmias (27 versus 9, p < 
0.0001). During a 16-month follow-up period, five patients in group I died, whereas 
none in group II died (p = 0.0271). Four deaths were related to arrhythmias. More 
group I patients were not functionally improved by the operation (17 versus 3, p = 
0.0056). The results of coronary artery bypass grafting in patients with significant 
chronic obstructive pulmonary disease were not favorable in midterm follow-up. A 
major cause for morbidity and mortality was postoperative arrhythmias. (J THORAC 
CAR9IOVASC SURG 1995;109:574-81) 
Amram Cohen, MD, a Michael Katz, MD, PhD, a Ramah Katz, MD, b 
Eli Hauptman, MD, a and Arieh Schachner, MD, a Holon and TeIAviv, Israel 
C hronic obstructive pulmonary disease (COPD) is 
common among patients undergoing coronary 
artery bypass grafting (CABG). 1 COPD has been 
considered as a risk factor for early mortality in 
patients undergoing CABG, and forced expiratory 
volume (FEV1) has been shown to be an indepen- 
dent risk factor for early mortality. 2 However, there 
has been no systematic evaluation of the patterns for 
morbidity or mortality in patients with COPD un- 
dergoing CABG. Furthermore, midterm follow-up 
has not been reported in this population. To address 
these questions, we evaluated our population with 
COPD undergoing CABG. 
Patients and methods 
Between June 1991 and June 1993, 651 patients under- 
went CABG at our institution. Of these, 37 patients 
(group I) were considered to have significant COPD. To 
be included in group I, the patient had to be actively 
treated and followed up for COPD in the pulmonary 
clinic. Further, the referring physician had to consider the 
COPD as dominant or codominant to the ischemic heart 
disease. These patients were compared with a population 
of 37 patients (group II) matched for age, sex, ejection 
fräction, and date of operation. Because there were no 
repeat operations in any of the group I patients, those 
undergoing reoperation were excluded from group II. For 
this study, heavy smoking was defined as more than 15 
cigarettes per day for more than 5 years. 
The groups were evaluated for p eoperative and oper- 
ative characteristics. The postoperative course, including 
length of intensive care unit stay, total hospitalization, 
morbidity, and 30-day mortality, were evaluated. 
During hospitalization, all patients were monitored 
continuously for arrhythmias. A bedside lectronic moni- 
tor was used when the patients were in the intensive care 
unit. When they were on the ward, they were monitored 
by telemetry to a control nursing station. Significant 
arrhythmias were considered to be those that occurred for 
more than 1 minute, those with malignant potential, or 
those that caused hemodynamic compromise. 
All patients in both groups or their families were 
contacted between July i and August 1, 1993. All survivors 
were assessed in out clinic to evaluate the postoperative 
course. This evaluation included a history of all readmis- 
sions to the hospital and their causes. Patients were asked 
to assess their present quality of life as compared with 
574 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 3 
Cohen et aL 575 
Table I. Preoperative patient characteristics 
Group I Group II 
Parameters (n = 37) (n = 37) p Value 
Male patients 31 (84%) 31 (84%) 
Female patients 6 (16%) 6 (16%) 
Age (mean -+ SD) 63.5 -+ 7.75 64.5 _. 7.18 0.5458 
Hypertension 13 (35.1%) 14 (37.8%) 0.632 
Diabetes mellitus 9 (24.3%) 11 (29.7%) 0.601 
Heavy smoker (>lS/day) 27 (72.9%) 19 (51.3%) 0.032 
Previous MI 29 (78.4%) 24 (64.9%) 0.197 
Unstable angina 24 (64.9%) 23 (62.1%) 0.809 
Ventricular ejection fraction (mean _+ SD) 44.8% +_ 10.04% 47.1% + 8.44% 0.3018 
Preop. arrhythmias 8 1 0.014 
Evidence of COPD on CXR 34 (91.9%) 5 (13.5%) <0.0001 
Admitted to hospital with shortness of breath 29 9 <0.0001 
SD, standard eviation; MI, myocardial infarction; CXR, chest roentgenogram; COPD, chronic obstructive pulmonary disease. 
their preoperative state. This evaluation encompassed 
exercise capability, breathing difficulty, and the ability to 
perform desired tasks. 
All patients had chest roentgenograms taken before 
operation and at the last follow-up. These were evaluated 
by a radiologist unfamiliar with the patients' clinical 
status. In evaluating the chest roentgenograms for 
COPD, the radiologist observed the posteroanterior and 
lateral films for evidence of retrosternal emphysema, 
flattened iaphrams, hyperexpansion of the lungs, and 
pulmonary vascularity. A significant finding in any of these 
categories was considered to be radiologic evidence for 
COPD. 
The postoperative films were examined for evidence of 
a new elevated iaphram and other pulmonary complica- 
tions. 
Pulmonary function tests were done in all patients in 
group I before operation and in all but one of the 
survivors at the last follow-up. In group Il, 12 patients had 
both preoperative and follow-up ulmonary function tests. 
Statistical analysis. For the comparison of categorical 
parameters between the two groups, the X 2 test was used. 
When the groups were too small, Fisher's exact est was 
used. For the determination of significant differences 
between the groups for quantitative parameters, a two- 
sample t test was applied. To analyze relationships be- 
tween two continuous parameters, Pearson's correlation 
analysis was applied. 
Results 
Preoperative characteristics. Preoperative char- 
acteristics of the patients in groups I and II are 
shown in Table I. There were no significant differ- 
ences in the demographic data for the two groups. 
Operative risk factors including diabetes, previous 
myocardial infarction, unstable angina, and ventric- 
ular ejection fraction were similar in the two groups. 
There were more significant arrhythmias before 
admission in group I (Table I). These consisted of 
atrial fibrillation (4), ventricular tachycardia (1), and 
multiple ventricular premature beats (VPBs) (>8/ 
min) or multifocal VPBs (3). More patients had 
been previously hospitalized for shortness of breath 
in group I (Table I). In 21 of the 29 hospitalized 
patients (group I), it was unclear whether the origin 
was cardiac or pulmonary. In the nine patients 
hospitalized before operation in group II, the short- 
ness of breath was clearly cardiac in origin. 
More patients in group I had a preoperative chest 
x-ray film compatible with COPD. The pulmonary 
function of the two groups is shown in Table II. 
Patients in group I had worse pulmonary function, 
lower preoperative arterial oxygen tension and high 
arterial carbon dioxide tension. 
Operative characteristics. All patients in both 
groups had elective or urgent operations. All were in 
hemodynamically stable condition when brought o 
the operating room. All patients underwent primary 
revascularization. Bypass was done in all patients 
with a single venous cannula. Moderate hypother- 
mia to 26°C and topical cooling with iced saline 
slush were used in all cases. The heart was vented 
through the right superior pulmonary rein in all 
cases. Myocardial protection was accomplished with 
the use of intermittent antegrade cold potassium 
cardioplegia. In selected cases intermittent sanguin- 
eous cardioplegia nd retrograde cardioplegia were 
used. Warm cardioplegia was not applied in this 
series. The details of the operations are shown in 
Table III. 
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Table I l. Pulmonary mechanics and arterial blood gas values 
Group I Group 11 
Parameters (n = 37) (n = 12) p Value 
Normalized by body surface area* 
Body surface 1.845 _+ 0.11 1.838 ___ 0.13 0.87 
Preop. FEV 1 (L) 0.750 _+ 0.17 1.270 --- 0.27 <0.0001 
Postop. FEV 1 (L) 0.66 _+ 0.18 1.33 _+ 0.34 <0.0001 
%A FEVIt  (L) -0.064 _+ 0.09 0.024 _+ 0.08 0.005 
Preop. FVC (L) 0.96 --_ 0.23 1.55 - 0.32 <0.0001 
Postop. FVC (L) 0.848 _ 0.25 1.53 _+ 0.38 <0.0001 
%A FVC:~ (L) 0.058 _+ 0.10 0.011 _+ 0.07 0.0563 
Preop. FEVJFVC (L) 0.43 - 0.05 0.448 + 0.05 0.4675 
Postop. FEVa/FVC (L) 0.426 -_+ 0.06 0.474 --_ 0.03 0.0053 
%A FEVJFVC (L) 0.006 ___ 0.08 -0.035 _+ 0.04 0.0329 
Preop. FEFzs.75 0.678 - 0.34 1.446 - 0.41 <0.0001 
Postop. FEF25.75 0.659 __+ 0.17 1.372 _+ 0.37 <0.0001 
%A FEF25.7» 0.019 -+ 0.40 0.007 + 0.18 0.6003 
Absolute values 
Preop. Pao2 (mm Hg) 63.5 --- 8.2 79.1 _+ 13.4 0.001 
Postop. Pao2 (mm Hg) 60.1 -+ 5.2 64.9 _+ 8.9 0.0063 
Preop. Paco2 (mm Hg) 44.8 ___ 6.5 39.7 --- 3.6 0.0001 
Postop. Paco z (mm Hg) 49.1 -+ 5.8 36.2 + 5.8 0.0001 
Values given as mean plus or minus the standard eviation. FVC, Forced vital capacity; FEF25_7» mean forced expiratory flow. Pao2, arterial oxygen tension; 
Paco2, arterial carbon dioxide tension. 
*Absolute values divided by body surface area. 
tPreop. FEV1 - Postop. FEV1 
Preop. FEV1 
:~Preop. FVC - Postop. FVC 
Preop. FVC 
Table HI. Operative data  
Group I Group H 
Parameters (n = 37) (n = 37) p Value 
Extent of disease trivessel or LM 
No. of grafts per patient (mean - SD) 
Internal mammary artery graft 
Cardiopulmonary b pass time (min) (mean + SD) 
Crossclamp time (min) (mean - SD) 
Intraaortic balloon 
26 (70.3%) 27 (73%) 0.797 
3.35 _+ 1.00 3.56 -+ 1.39 NS 
35 (94.6%) 33 (89.2%) 0.199 
171.9 --- 45.7 156.2 + 45.7 0.1611 
75.45 _+ 17.9 69.2 -+ 21.8 0.2106 
2 0 
LM, Left main coronary artery; SD, standard eviation; NS, not significant. 
Postoperative characteristics. Table IV displays 
the postoperative results. The patients in group I 
had longer intensive care unit stays and longer total 
hospitalization. A significantly higher percentage of 
patients in group I required prolonged intubation or 
reintubation. Elevated left hemidiaphragm devel- 
oped in more patients in group I with COPD in the 
postoperative period. There was a highly significant 
difference in the development of postoperative ar- 
rhythmias between the two groups. In group I 
significant arrhythmias developed in 27 (73%) of 37 
patients. These included atrial fibrillation, atrial 
flutter, supraventricular tachycardia, ventricular fi- 
brillation and, multiple VPBs (>8/min) or multi- 
focal VPBs. A combination of these arrhythmias 
developed in 11 patients. In 15 patients the arrhyth- 
mias were hemodynamically significant and caused 
hypotension. In group II, there were 9 (24%) pa- 
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Fig. 1. Comparison of number of hospital admissions and causes of admission in patient population during 
follow-up period. 
Table IV. Postoperative data and type of  complications 
Group I Group H 
Pararneters/complications (n = 37) (n = 37) p Value 
Days of hospitalization (mean + SD) 
Intensive care unit stay (days) (mean + SD) 
Reintubation 
Intubation >48 hr 
Postoperative pneumonia 
Bronchospasm necessitating travenous treatment 
Diaphragm elevation 
Significant arrhythmia 
Hemodynamic eompromise with arrhythmias 
8,1 + 3.6 6.6 -+ 1.7 0.0263 
2.64 -+ 0.98 1.23 + 0.49 0,0001 
5 (13.5%) 1 (3.7%) 0.088 
7 (18.9%) 1 (3.7%) 0.0278 
3 (8.1%) 0 (0%) 0.24 
13 (35.1%) 2 (5.4%) 0.001 
17 (45.9%) 4 (10.8%) <0.0001 
27 (73%) 9 (24.3%) <0.0001 
15 (43.7%) 0 (0%) <0.0001 
SD, Standard devi~ion. 
tients in whom significant arrhythmias developed, 
including atrial fibrillation and flutter, supraventric- 
ular tachycardia, nd multiple or multifocal VPBs. 
No ventricular tachycardia or fibrillation developed 
in this group and none of the arrhythmias was 
hemodynamically significant. 
FoUow-up 
Mortality. Group I had a follow-up of 13.8 -+ 7.20 
months, and group II had a follow-up of 14.1 +_ 6.90 
months. There was no early or late mortality in 
group II. In group I, there were two early and three 
late deaths, of which four could be related to 
arrhythmias and one to pulmonary complications. 
The early deaths included a patient who had a 
routine postoperative course, then died of sudden 
ventricular fibrillation on postoperative day 3. The 
second patient was discharged after a routine 7-day 
postoperative course, and he died suddenly at home 
on postoperative day 9. 
Of the late deaths, two were also related to 
arrhythmias. One patient, with poor ejection frac- 
tion, was readmitted to the hospital 2 months after 
578 Cohen et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
March 1995 
No. of patients 
50- 
40 
30 
20 
Group I Group II 
P(O.O001 
1o 
0 
Better Worse .Sarne Better Worse Same 
Fig. 2. Results of quality-oßlife questionnaire showing patients' assessment of quality of life at last 
follow-up compared with preoperative status. 
discharge with atrial fibrillation and heart failure. 
He died during the hospitalization of multiple 
organ failure. The third patient had acute atrial 
fibrillation 4 weeks after operation. Concurrent 
with the arrhythmia, dense right-sided hemiplegia 
developed. She died after 3 weeks of hospitaliza- 
tion. The fourth patient died 10 months after 
operation. She had been hospitalized four times 
for shortness of breath and died of respiratory 
insufficiency. 
Morbidity. During the follow-up period, there 
were significantly more complications among group 
I patients. Twenty-four of the 37 patients were 
rehospitalized after CABG, with a total of 44 hos- 
pital admissions. Fourteen patients were hospital- 
ized multiple times (Fig. 1). Readmissions were due 
to respiratory symptoms (n = 31), arrhythmias (n = 
5), recurrent ischemia (n = 2), uncontrolled iabe- 
tes (n = 1), mediastinitis (n = 3), superficial wound 
infection (n = 1), and uncontrolled hypertension 
(n = 1). Four patients with arrhythmias had 
significant sequelae. These included two patients 
who required femoral embolectomy for emboli 
that occurred during atrial fibrillation. One pa- 
tient had right hemiparesis that totally resolved, 
and one had transient monocular blindness con- 
current with atrial arrhythmias. In all instances, 
the patients were in atrial fibrillation on readmis- 
sion to the hospital, whereas they had been dis- 
charged from the cardiac service in normal sinus 
rhythm. In group II, there were 12 readmissions to
the hospital because of respiratory symptoms (n = 
3), arrhytbmias (n = 2), recurrent ischemia (n = 
1), diabetes (n = 1), superficial wound infection 
(n = 3), uncontrolled hypertension (n = 1), and 
lung cancer (n -- 1). 
Present condition. Late chest roentgenograms 
showed a significant increase in the number of 
patients with an elevated left diaphragm in group 
I (Table I, p < 0.0001). Preoperative and late 
postoperative r sults of pulmonary function tests 
are shown in Table Il. In group I, FEV 1 was 
reduced by 0.118 + 0.17 L at the late follow-up 
and was increased by 0.045 + 0.14 L in group II 
(p = 0.0039). 
The results of our quality of life evaluation are 
shown in Fig. 2. Of the 32 surviving patients in 
group I, 12 (37%) believed that their physieal 
abilities to do desired tasks were reduced after the 
operation, 15 patients subjectively felt an im- 
provement, and 5 remained unchanged. In group 
II, 34 (91.9%) patients believed that the operation 
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had improved their conditions, 1 felt worse, and 2 
remained unchanged (p = 0.0056). 
Diseussion 
COPD and atherosclerotic cardiovascular disease 
commonly occur among the same patient popula- 
tion. 1 The importance of the cardiovascular re- 
serve in patients undergoing pulmonary resection 
is recognized. 3 The effect of respiratory reserve on 
patients undergoing CABG is not well delineated. 
Our hypothesis was that a limited pulmonary 
reserve is a major cause of poor immediate and 
intermediate results in patients undergoing 
CABG. 
Definition of COPD. Attempts have been made 
to establish COPD as a risk factor for mortality in 
patients undergoing CABG. 4"6 The Society of Tho- 
racic Surgeons established COPD as an operative 
risk factor, 5 and the Cleveland Clinic Scorc has 
alloted COPD a value of 1. 6 The Veterans Admin- 
istration showed patients undergoing CABG with an 
FEV 1 less than 1.25 L to have a significantly higher 
acute mortality rate. 2 However, detailed analysis of 
the influence of COPD on patients undergoing 
CABG has not been done. 
Part of the problem is defining significant COPD. 
Whereas the definition of severe COPD is well 
established with the use of laboratory parameters, 
these patients are clearly too ill to undergo 
CABG.7, 8 In an attempt to overcome this problem, 
we elected to define our population on the basis of 
clinical criteria, as described in the Patients and 
methods ection. The laboratory and radiologic data 
from this group of patients confirmed that the 
patients in this group had moderate to severe 
COPD. Our clinical definition was sufficiently broad 
to include 5.7% of our CABG population. It was 
specific enough that when this group of patients with 
clinical COPD was compared with the control 
group, the highly significant effect of COPD was 
evident. 
Arrhythmias. The association of COPD with an 
increased incidence of ventricular and supraventric- 
ular arrhythmias is weil established. 9' 10 This was 
confirmed by our study with a higher incidence of 
preoperative arrhythmia in group I patients. Ar- 
rhythmias, especially supraventricular rhythmias, 
are common after CABG. n' 12 Risk factors known 
to be associated with the development of these 
arrhythmias include increased age and withdrawal 
from/3-blockers. 13'14 Other factors, including arte- 
rial blood gas levels, have been studied as potential 
risk factors for supraventricular rhythmias after 
CABG, but no correlation has been found. 14'15 
COPD has been identified as a risk factor for 
postoperative atrial arrhythmias in a recent study, 
but COPD is not defined in that paper. 16 
There was a large increase in the number of 
patients with significant arrhythmias in group I, 
implicating clinical COPD as a risk factor for ar- 
rhythmias after CABG. Furthermore, ventricular 
fibrillation and tachycardia developed only in group 
I patients. Hemodynamic compromise because of 
arrhythmias occurred only in group I patients, and 
arrhythmias in this group were a major cause of 
morbidity and mortality. 
Hemodynamic compromise with atrial fibrillation 
has previously been associated with poor left ven- 
tricular systolic and diastolic function, hyper- 
trophied myocardium, ischemic myocardium, and 
duration of arrhythmia. 17 Atrial fibrillation after 
CABG is usually benign and of short duration, and 
the CABG itself has greatly reduced the ischemic 
jeopardy of the myocardium. 17Our data implicate 
COPD as a risk factor for hemodynamic compro- 
mise during atrial arrhythmia in patients after 
CABG. 
Pulmonary eomplieations. Increased postopera- 
tive pulmonary morbidity in patients with COPD is 
documented. 18 In patients undergoing CABG, the 
effects of sternotomy and bypass on pulmonary 
function will reduce FEV 1 in the postoperative 
period to two thirds the amount of its preoperative 
value.18,19 In patients with COPD, this acute post- 
operative reduction in FEV1 will accentuate their 
underlying condition to increase postoperative mor- 
bidity. As such, out findings of increased reintuba- 
tion, length of intubation, and length of hospital stay 
in group I are all consistent with data from previous 
reports.18, 20 
Infeetion. There were three episodes of medias- 
tinitis in group I and none in group II. Chronic 
pulmonary disease has been documented as a risk 
factor for mediastinitis after CABG. 21' 22 
Mortality. Over a mean of 14 months of follow- 
up, there was a significant difference in the mortality 
between groups. An FEV 1 of less than 1.25 L has 
been shown to increase the risk of acute mortality. • 
Intermediate mortality and an analysis of the causes 
of death have not been previously reported. Our 
analysis hows that the major cause of mortality was 
arrhythmia: 4 of 5 patients who died had arrhythmia 
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as the direct or precipitating cause of death. The 
lethal arrhythmias were distributed equally between 
the immediate postoperative period and follow-up 
period. It should also be noted that 23 of out 
patients had an FEV1 greater than 1.25 L. This 
again emphasizes the need to use clinical COPD as 
the risk factor and not a single laboratory value 
associated with the disease. 
Quality of life. It is frequently ditficult to differ- 
entiate cardiac from pulmonary causes of dyspnea. 23 
Thus a patient with COPD who is seen with short- 
ness of breath as a manifestation f cardiac disease 
may not have the symptoms alleviated by CABG. In 
addition, injury to the pulmonary system during 
CABG may result in alleviation of the cardiac 
symptoms and exacerbation of pulmonary symp- 
toms, resulting in little symptomatic benefit to the 
patient. 
Our analysis seems to confirm this concern. In 
group I, 24 patients had to be rehospitalized during 
the follow-up period. Further, only 15 believed that 
their physical condition improved after CABG; 12 
believed that it worsened. This contrasts with the 
results in group II, whose patients enjoyed the 
results of CABG as previously described in the 
literature. 24 
Thus, on the basis of the data collected, our 
impression is that the following conclusions are 
warranted: (1) Clinical COPD is a significant factor 
for morbidity and mortality after CABG, (2) a large 
portion of the morbidity and mortality may be due 
to an increase in significant postoperative arrhyth- 
mias, and (3) the clinical benefits of CABG reported 
in the literature are significantly reduced among this 
patient population, 
We suggest he following recommendations: (1)
Because of high (or higher) mortality and reduced 
benefit, indications for CABG in this group of 
patients hould be restricted and (2) postoperative 
prophylaxis against arrhythmias should be used in 
this group of patients and maintained indefinitely. 
This article was prepared in consultation with Eliezer 
Jucha, who performed the statistical calculations, and with 
the technical assistance of Sally Esakov. 
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